On August 4–5, the AI×MedTech Asia Innovation Challenge, jointly organized by the Aichi Prefectural Government and Fujita Health University, was held at Station Ai in Nagoya, Japan. As a major gathering for AI-driven healthcare innovation in Asia, the event brought together more than 20 companies from Japan, China, South Korea, Singapore, and other Asian markets, along with leading Japanese medical device manufacturers, distributors, academic institutions, and media organizations. Participants explored emerging trends and business opportunities at the intersection of artificial intelligence and healthcare.
A Leading Platform for AI Healthcare Innovation
The Aichi Prefectural Government has continued to advance its AI healthcare strategy, working to establish the prefecture as a leading medical technology innovation hub in Asia. Fujita Health University, one of Japan’s leading private medical universities, is highly regarded for its work in clinical medicine, biomedical engineering, and interdisciplinary research. By bringing government and academia together, the event provided Asian AI healthcare companies with a high-level platform for presentation and exchange while creating an important bridge between technological innovation and real-world adoption. Leaders from both organizing institutions attended the conference and delivered remarks.
Fertsy Represents China’s AI Healthcare Innovators
Fertsy Inc was invited to participate as a representative of China’s AI healthcare sector. Fertsy delivered a presentation introducing its technology portfolio in AI-assisted reproductive medicine, its international product strategy, and its latest progress in the Japanese market.
During the event, the Fertsy team held a series of in-depth one-on-one meetings with Fujita Health University, major Japanese medical device manufacturers, and local distributors. The discussions covered technology partnerships, product implementation, market access, and channel development, with the aim of identifying practical paths for China–Japan collaboration in AI healthcare.
A Fertsy representative was also interviewed by NNA, a leading Asian business news organization, and shared perspectives on the development of China’s AI healthcare industry, the company’s approach to technological innovation, and its international growth strategy.
Deepening Fertsy’s Presence in Asia Through Cross-Border Collaboration
The visit to Nagoya marked another important step in Fertsy’s expansion across Asia. Through direct dialogue with a leading Japanese medical university, established industry players, and professional media, the company gained further insight into the potential applications of AI healthcare technologies in Japan and the opportunities for future collaboration.
Fertsy will continue to embrace open collaboration, take part in leading international industry exchanges, and bring independently developed Chinese AI healthcare technologies to a broader global market—contributing practical solutions to the intelligent transformation of healthcare worldwide.
